Baird analyst Eric Coldwell lowered the firm’s price target on Owens & Minor to $20 from $24 and keeps a Neutral rating on the shares. The firm noted its valuation pressure continues post Q1 results and outlook, with further recent pressure stemming from GLP-1 knock-on fears, though no negative impacts have been cited to date.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on OMI: